Mandel-Brehm Josh
Chief Executive Officer
Mandel-Brehm Josh has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2025. 1 of those filings fall inside the rolling window. Most recent filing: Aug 5, 2026.
On the most recent filing, Mandel-Brehm Josh is listed as Chief Executive Officer at Camp4 Therapeutics Corp. Inside the rolling window, Mandel-Brehm Josh reported 1 open-market purchase totaling $11K in CAMP and no open-market sales.
Companies traded
Other insiders at CAMP
Insider Buying
$11K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Sep 11, 2025 | CAMP | Purchase | $10K |
Frequently asked questions
How many SEC Form 4 filings has Mandel-Brehm Josh made?
Mandel-Brehm Josh has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2025.
Which companies does Mandel-Brehm Josh trade?
Mandel-Brehm Josh has filed SEC Form 4 disclosures for 1 company, including CAMP.
When was Mandel-Brehm Josh's most recent SEC Form 4 filing?
Mandel-Brehm Josh's most recent SEC Form 4 filing on Tracefour is dated Aug 5, 2026.
What is Mandel-Brehm Josh's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Mandel-Brehm Josh is listed as Chief Executive Officer.
What is Mandel-Brehm Josh's total buy and sell value in the current window?
Inside the rolling retention window, Mandel-Brehm Josh bought $11K and sold $0 based on SEC Form 4 filings.
What was Mandel-Brehm Josh's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 6,551 CAMP shares on 2026-08-03, worth $11K, per SEC Form 4 filings.